Patent · US Active

Anaeroplasmatales for use in the treatment or prevention of an inflammatory disorder of the digestive system

US11007234B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

DEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN · DE

Inventors

Hyun-Dong Chang · Berlin, DE
Alexander Beller · Berlin, DE
Andreas Radbruch · Bonn, DE

Key dates

Filing date	Sep 7, 2018
Grant date	May 18, 2021
Priority date	—
Expiry date	Jan 24, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/0056
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A composition including one or more bacteria of the order Anaeroplasmatales for use as a medicament in methods of treatment or prevention of an inflammatory disorder of the digestive system. Preferred embodiments of the invention relate to methods employing Anaeroplasma in the treatment or prevention of an inflammatory disorder of the digestive system. Preferably, the inflammatory disorders of the digestive system are inflammatory bowel disease, colitis, Crohn's disease (CD) or ulcerative colitis (UC). Furthermore, it is preferable that the composition of the present invention causes increased TGF-β and/or IgA production in the intestine or other component of the digestive tract compared to subjects who have not received administration of the composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.